Description

The global estradiol market size is expected to witness a CAGR of 6.8% over the forecast period (2021-2027). Estradiol is a medication used to treat low sex hormone levels and menopausal hormone therapy in women. It is responsible for maintaining and developing female characteristics and reproductive tissues such as the uterus, mammary glands, and vagina.

Factors Affecting the Estradiol Industry over the Forecast Period:

The sedentary lifestyle is leading to the rising number of women's health-related disorders across the globe; therefore, considerable growth in the estradiol market can be expected over the forecast period. Moreover, the rising medical tourism in Singapore, India contributes to the growth of the estradiol market in the Asia Pacific.

However, the side effects of estradiol drugs, such as anxiety, abdominal cramping, breast enlargement, freckles on facial skin, bloating, and bleeding, may restrain the growth of estradiol drugs globally market over the forecast period.

Impact of COVID-19 on Estradiol Market:

The COVID-19 pandemic has dramatically affected the global sales of the estradiol market. The new diagnosis of indications has seen a decline, backed by the decline in hospital visits amidst the widespread COVID-19 across the globe. However, a certain downfall was covered by the regular sales of the already prescribed estradiol drugs. Therefore, a moderate downfall can be estimated in the estradiol market value in 2020.

Scope of the Report

The report outlines the global estradiol market study based on type, route of administration, indication, and application.

The estradiol market has been segmented based on type –

• α-Estradiol
• β-Estradiol

The estradiol market has been segmented based on the route of administration –

• Oral
• Injectable
• Topical
• Transdermal

The estradiol market has been segmented based on indication –

• Estrogen Deficiency
• Metastatic Breast Cancer (MBC)
• Atrophic Vaginitis
• Postmenopausal Osteoporosis (PMO)
• Others

The estradiol market has been segmented based on application –

• Pharmaceutical
• Biological Research
• Others

Estradiol Market: Regional Outlook

Based on the region, the global estradiol market has been segmented into five geographical regions, namely, North America, Asia Pacific, Europe, South America, and the Middle East and Africa. In 2020, North America held the largest share in the estradiol market, followed by the Asia Pacific and Europe. North America is expected to retain its dominant position over the forecast period. Moreover, Asia Pacific is expected to project the highest CAGR globally over the forecast period.

Key Global Estradiol Market Competitors Includes –

The estradiol market has a presence of a few market players across the globe. The key estradiol market players operating in the global market are –

• Bayer AG
• Guangzhou Wondfo Biotech
• Jiangxi Yuneng Pharmaceuticals
• Lupin
• Merck KGaA
• Mylan NV
• Nanjing Habo Medical Technology Co.
• Novartis International AG
• Pharmacia & Upjohn
• Shanghai Lianlu Industry Co. Ltd.
• Symbiotech Pharma
• Valdepharm
• Wuhan Dongkangyuan Technology Co. Ltd.
• Zhejiang Ruiyang Pharm.

The estradiol tools market report provides a thorough analysis of macro-economic factors and every segment's market attractiveness. The report will include an in-depth qualitative and quantitative assessment of the segmental/regional outlook with the market players' presence in the respective segment and region/country. The information concluded in the report includes the inputs.

Estradiol Market Report Covers Comprehensive Analysis On:

• Market Segmentation & Regional Analysis
• Market Size of 10 years
• Pricing Analysis
• Supply & Demand Analysis
• Product Life Cycle Analysis
• Porter's Five Forces & Value Chain Analysis
• Developed & Emerging Economies Analysis
• PEST Analysis
• Market and Forecast Factor Analysis
• Market Opportunities, Risks, & Trends
• Conclusion & Recommendation
• Regulatory Landscape
• Patent Analysis
• Competition Landscape
• 15+ Company Profiles

Estradiol Market Regional Analysis Includes:

• North America (US, Canada, Mexico)
• South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
• Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)
• Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific)
• The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA

Estradiol Market: Target Audience

• Estradiol drug manufacturers
• Investors and trade experts
• Large, medium, and small-sized enterprises
• Estradiol drug distributors and suppliers
• Trade publications and magazines
• Government authorities, associations, and organizations

Key Issues Addressed

• What is the market size by various segmentation of the estradiol by region and its respective countries?
• What are the customer buying behavior, key takeaways, and Porter's 5 forces of the estradiol market?
• What are the key opportunities and trends for manufacturers involved in the estradiol supply chain?
• What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market?
• What and how regulations, schemes, patents, and policies are impacting the growth of the market?
• What are the upcoming technological solutions influencing market trends? How will existing companies adapt to the new change in technology?
• What will be the impact of cutting-edge technology on the estradiol market?
• How has COVID-19 impacted the demand and sales of estradiol in the global market? Also, the expected BPS drop or rise count of the market and market expected recovery period.
• Detailed analysis of the competitors and their latest launch, and what are the prominent startups introduced in the target market? Also, detailed company profiling of 25+ leading and prominent companies in the market.